October marks Breast Cancer Awareness Month, a time dedicated to raising awareness about breast health and the importance of early detection. This year, The Estée Lauder Companies have launched the ...

After 3 years of follow-up in the Mammary Prevention 3 (MAP.3) randomized trial, women who took exemestane were 65% less likely than those who took a placebo to develop breast cancer. 8 With 7 years ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Unopposed estrogen hormone therapy (E-HT) reduces breast cancer risk, while estrogen plus progestin hormone therapy (EP-HT) increases it, especially with long-term use. The study analyzed data from ...